We seek collaboration with industry leaders through strategic partnerships for expanding our product portfolio, and to take advantage of the Cysbio technology platform.
Cysbio offers extensive expertise in metabolic engineering, synthetic biology and fermentation processes. We see our collaborations as long-term investments in future business development.
Cysbio has received two grants from the EU’s “Horizon 2020” program.
One grant is under the program Horizon 2020, EIC (European Innovation Council) to develop amino acids for use in food and animal feed.
The second grant is the Horizon 2020, FTI (Fast Track Innovation) program and focuses on completion, upscaling, and initial production of zosteric acid (eelgrass acid).
Both programs extends over 30 months and will be completed in 2023.
It is our ground-breaking research that has paved the way for these grants, which will accelerate the development work and allow faster product introductions.